125 related articles for article (PubMed ID: 28730390)
21. Generation of Induced Pluripotent Stem Cells from Mammalian Endangered Species.
Ben-Nun IF; Montague SC; Houck ML; Ryder O; Loring JF
Methods Mol Biol; 2015; 1330():101-9. PubMed ID: 26621593
[TBL] [Abstract][Full Text] [Related]
22. Generation of Avian Induced Pluripotent Stem Cells.
Lu Y; West FD; Jordan BJ; Beckstead RB; Jordan ET; Stice SL
Methods Mol Biol; 2015; 1330():89-99. PubMed ID: 26621592
[TBL] [Abstract][Full Text] [Related]
23. Generation of Footprint-Free Induced Pluripotent Stem Cells from Human Fibroblasts Using Episomal Plasmid Vectors.
Ovchinnikov DA; Sun J; Wolvetang EJ
Methods Mol Biol; 2015; 1330():37-45. PubMed ID: 26621587
[TBL] [Abstract][Full Text] [Related]
24. Enhancing mammary differentiation by overcoming lineage-specific epigenetic modification and signature gene expression of fibroblast-derived iPSCs.
Li Y; Hong N; Zhang A; Chen W; Wang RH; Xu XL; Deng CX
Cell Death Dis; 2014 Dec; 5(12):e1550. PubMed ID: 25476898
[TBL] [Abstract][Full Text] [Related]
25. Generation of keratinocyte stem-like cells from human fibroblasts via a direct reprogramming approach.
Zhao A; Yang Y; Pan X; Pan Y; Cai S
Biotechnol Prog; 2020 May; 36(3):e2961. PubMed ID: 31930712
[TBL] [Abstract][Full Text] [Related]
26. A feeder- and xeno-free human induced pluripotent stem cell line obtained from primary human dermal fibroblasts with epigenetic repression of reprogramming factors expression: GPCCi001-A.
Lach MS; Wroblewska JP; Augustyniak E; Kulcenty K; Suchorska WM
Stem Cell Res; 2017 Apr; 20():34-37. PubMed ID: 28395738
[TBL] [Abstract][Full Text] [Related]
27. [Reprogramming of somatic cells. Problems and solutions].
Schneider TA; Fishman VS; Liskovykh MA; Ponamartsev SV; Serov OL; Tomilin AN; Alenina N
Tsitologiia; 2014; 56(12):869-80. PubMed ID: 25929128
[TBL] [Abstract][Full Text] [Related]
28. Rapid and efficient CRISPR/Cas9 gene inactivation in human neurons during human pluripotent stem cell differentiation and direct reprogramming.
Rubio A; Luoni M; Giannelli SG; Radice I; Iannielli A; Cancellieri C; Di Berardino C; Regalia G; Lazzari G; Menegon A; Taverna S; Broccoli V
Sci Rep; 2016 Nov; 6():37540. PubMed ID: 27857203
[TBL] [Abstract][Full Text] [Related]
29. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
30. Stem cells: The black box of reprogramming.
Cyranoski D
Nature; 2014 Dec; 516(7530):162-4. PubMed ID: 25503218
[No Abstract] [Full Text] [Related]
31. Enhancing Induced Pluripotent Stem Cell Generation by MicroRNA.
Dang J; Rana TM
Methods Mol Biol; 2016; 1357():71-84. PubMed ID: 25687299
[TBL] [Abstract][Full Text] [Related]
32. Purification of functional reprogramming factors in mammalian cell using FLAG -Tag.
Han MJ; Kim HR; O'Reilly C; Kim CH
Biochem Biophys Res Commun; 2017 Oct; 492(2):154-160. PubMed ID: 28802578
[TBL] [Abstract][Full Text] [Related]
33. Comparative epigenetic evaluation of human embryonic stem and induced pluripotent cells.
Favaedi R; Shahhoseini M; Pakzad M; Mollamohammadi S; Baharvand H
Int J Dev Biol; 2016; 60(4-6):103-10. PubMed ID: 27389983
[TBL] [Abstract][Full Text] [Related]
34. Cell reprogramming into the pluripotent state using graphene based substrates.
Yoo J; Kim J; Baek S; Park Y; Im H; Kim J
Biomaterials; 2014 Sep; 35(29):8321-9. PubMed ID: 24996757
[TBL] [Abstract][Full Text] [Related]
35. Repeated human deciduous tooth-derived dental pulp cell reprogramming factor transfection yields multipotent intermediate cells with enhanced iPS cell formation capability.
Soda M; Saitoh I; Murakami T; Inada E; Iwase Y; Noguchi H; Shibasaki S; Kurosawa M; Sawami T; Terunuma M; Kubota N; Terao Y; Ohshima H; Hayasaki H; Sato M
Sci Rep; 2019 Feb; 9(1):1490. PubMed ID: 30728386
[TBL] [Abstract][Full Text] [Related]
36. Ectopic expression of CITED2 prior to reprogramming, promotes and homogenises the conversion of somatic cells into induced pluripotent stem cells.
Charneca J; Matias AC; Escapa AL; Fernandes C; Alves A; Santos JMA; Nascimento R; Bragança J
Exp Cell Res; 2017 Sep; 358(2):290-300. PubMed ID: 28684114
[TBL] [Abstract][Full Text] [Related]
37. Modeling Andersen's Syndrome in Human Induced Pluripotent Stem Cells.
Pini J; Rouleau M; Desnuelle C; Sacconi S; Bendahhou S
Stem Cells Dev; 2016 Jan; 25(2):151-9. PubMed ID: 26573604
[TBL] [Abstract][Full Text] [Related]
38. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
[TBL] [Abstract][Full Text] [Related]
39. Nucleolar molecular signature of pluripotent stem cells.
Pliss A; Kuzmin AN; Kachynski AV; Jiang H; Hu Z; Ren Y; Feng J; Prasad PN
Anal Chem; 2013 Apr; 85(7):3545-52. PubMed ID: 23458184
[TBL] [Abstract][Full Text] [Related]
40. Phenotypical Differences in Neuronal Cultures Derived via Reprogramming the Fibroblasts from Patients Carrying Mutations in Parkinsonian Genes LRRK2 and PARK2.
Konovalova EV; Novosadova EV; Grivennikov IA; Illarioshkin SN
Bull Exp Biol Med; 2015 Oct; 159(6):772-5. PubMed ID: 26519280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
